Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Int J Antimicrob Agents. 2019 Oct 26;55(3):105828. doi: 10.1016/j.ijantimicag.2019.10.009

Fig. 2.

Fig. 2.

Total protease inhibition activity of auranofin and linezolid against vancomycin-resistant E. faecium NR-31909. Data are presented as percent protease production of each drug (tested in sexruplicate). TSB with skim milk served as a negative control. Data were analyzed via unpaired Student t test (p<0.05). Auranofin was compared to untreated (*) and to linezolid (#).